reports

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

July 18, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical…

5 months ago

Euroclear reports robust H1 2025 results

BRUSSELS, July 18, 2025 /PRNewswire/ -- Results for the first half year ended 30 June 2025 Financial highlights Solid business…

5 months ago

Bank of America Reports Second Quarter 2025 Financial Results

CHARLOTTE, N.C., July 16, 2025 /PRNewswire/ -- Bank of America reported its second quarter 2025 financial results today. The news…

6 months ago

ESD Alliance Reports Electronic System Design Industry Posts $5.1 Billion in Revenue in Q1 2025

All Geographic Regions Reported Growth, with Americas, EMEA, and Japan Recording Double Digit Increases MILPITAS, Calif., July 15, 2025 /PRNewswire/…

6 months ago

Cyble Recognized as a Sample Vendor in Three Gartner Hype Cycle Reports for the Second Consecutive Year

CUPERTINO, Calif., July 14, 2025 /PRNewswire/ -- Cyble, a global leader in AI-native cybersecurity solutions is pleased to announce its recognition…

6 months ago

Baazar Style Retail Limited Reports Robust 37% Revenue Growth in Q1 FY26

Continues Expansion with 22 New Stores; Maintains Strong Momentum in Value Fashion Segment KOLKATA, India, July 8, 2025 /PRNewswire/ --…

6 months ago

OMAN INVESTMENT AUTHORITY REPORTS USD 4.1 BILLION PROFIT FOR 2024, RANKS AMONG TOP 10 GLOBAL SOVEREIGN FUNDS

MUSCAT, Sultanate of Oman, July 2, 2025 /PRNewswire/ -- Oman Investment Authority (OIA), the Sultanate's sovereign wealth fund, closed 2024…

6 months ago

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646…

6 months ago

Actuate Therapeutics Reports Positive Biomarker and Machine Learning Data from Phase 2 Elraglusib Trial in First-Line Treatment of Metastatic Pancreatic Cancer at ASCO

Phase 2 highlights robust biomarker identification and survival correlations in first-line metastatic pancreatic cancer (mPDAC) treated with elraglusib June 20,…

6 months ago

Clarivate Unveils the 2025 Journal Citation Reports

50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider…

6 months ago